Michael E. Morgan, Ph.D. Email and Phone Number
Michael E. Morgan, Ph.D. work email
- Valid
- Valid
Michael E. Morgan, Ph.D. personal email
Michael E. Morgan, Ph.D. phone numbers
I am personable, highly motivated and a self-titled science geek. Over 15+ years, I have obtained a comprehensive understanding of biopharmaceutical research and drug development. My principal strengths are DMPK analyses of preclinical and Phase 1 clinical modalities in multiple therapeutic areas. I have excellent oral communication and scientific writing skills. My backgrounds includes 60+ scientific meeting presentations, 40+ peer reviewed articles and 2+ patents. (see accomplishments)
-
Sr. Director, DmpkHelus PharmaSan Diego, Ca, Us
-
Sr. Director DmpkCybin Inc. Oct 2021 - PresentToronto, Ontario, Ca -
Dmpk ConsultantMorgan Pharmaceutical Research 2016 - Oct 2021Expertise: • Preclinical Pharmacokinetics• Toxicokinetics/Drug Safety• Clinical Pharmacokinetics• Pharmacokinetic modeling• Medical/Scientific Writing Clients:• Acadia Pharmaceuticals, Inc.• Arena Pharmaceuticals, Inc.• Beacon Discovery• Circumvent• Intercept Pharmaceuticals• LifeStar Pharma LLC• Outpost Medicine Limited
-
Director, Clinical PharmacologyMirati Therapeutics Aug 2019 - Jan 2020San Diego, California, Us -
Senior Director, PharmacokineticsArena Pharmaceuticals 2013 - Sep 2016San Diego, Ca, UsLed DMPK Discovery, Preclinical, Toxicology, and Clinical Programs.Member of the Senior Leadership Forum• Participated in 9+ programs that moved compounds forward to the next level of investigation• Coordinated, authored, and edited DMPK IND and NDA sections (4 INDs; 2 NDAs) for successful applications of 4+ new drug candidates• Analyzed, co-authored, and edited Clinical Study Reports (1 Phase 1a, 1 Phase 1b; 1 BE; 1 fed v. fasted) that resulted in FDA approval of the use of a new drug formulation for Belviq®• Modeled population pharmacokinetic and pharmacodynamic relationships that resulted in the scientific understanding of the drug response and drug concentration relationships -
Director, PharmacokineticsArena Pharmaceuticals 2008 - 2013San Diego, Ca, UsGuided DMPK Discovery, Preclinical, Toxicology, and Clinical Programs• Participated in 5+ programs that moved compounds forward to the next level of investigation• Contributed to the analyses, coauthored, and edited the population PK and population PK/PD Phase 3 report that resulted in the FDA approval of Belviq®• Analyzed, co-authored, and edited preclinical PK and TK reports that moved compounds forward to the next level of investigation • Analyzed, co-authored, and edited Clinical Study Reports (5 Phase 1a, 5 Phase 1b; 2 Phase 3) that resulted in the FDA approval of Belviq®
-
Associate DirectorArena Pharmaceuticals 2005 - 2008San Diego, Ca, UsBuilt strong scientific DMPK portfolios for advancing drug candidates• Participated in 9+ programs that moved compounds forward to the next level of investigation• Initiated and completed 21CRF Part 11 compliance for WinNonlin that resulted GLP compliant PK and TK analyses • Analyzed, authored, and edited preclinical PK, TK and Clinical Studies Reports that moved compounds forward to the next level of investigation
-
Senior ScientistArena Pharmaceuticals 2004 - 2005San Diego, Ca, UsBuilt strong scientific DMPK portfolios for advancing drug candidates• Participated in 9+ programs that moved compounds forward to the next level of investigation• Instituted one-page PK data summaries that resulted in improved communication with the project teams• Analyzed, authored, and edited preclinical PK and TK reports that moved compounds forward to the next level of investigation
-
ScientistArena Pharmaceuticals 2003 - 2004San Diego, Ca, UsEstablished scientific rigor within the PK team• Participated in 9+ programs that moved compounds forward to next level of investigation• Designed protocols for PK in-life experiments and developed new procedures that resulted in an 50% increase in the number of animal experiments performed
Michael E. Morgan, Ph.D. Skills
Michael E. Morgan, Ph.D. Education Details
-
Idaho State UniversityMicrobiology And Biochemistry -
University Of UtahPharmacology
-
University Of Colorado Medical CenterClinical Pharmacology
Frequently Asked Questions about Michael E. Morgan, Ph.D.
What company does Michael E. Morgan, Ph.D. work for?
Michael E. Morgan, Ph.D. works for Helus Pharma
What is Michael E. Morgan, Ph.D.'s role at the current company?
Michael E. Morgan, Ph.D.'s current role is Sr. Director, DMPK.
What is Michael E. Morgan, Ph.D.'s email address?
Michael E. Morgan, Ph.D.'s email address is mm****@****arm.com
What is Michael E. Morgan, Ph.D.'s direct phone number?
Michael E. Morgan, Ph.D.'s direct phone number is (858)-453*****
What schools did Michael E. Morgan, Ph.D. attend?
Michael E. Morgan, Ph.D. attended Idaho State University, University Of Utah, University Of Colorado Medical Center.
What skills is Michael E. Morgan, Ph.D. known for?
Michael E. Morgan, Ph.D. has skills like Drug Development, Pharmacokinetics, Dmpk, Biotechnology, Pharmacology, Ind, Clinical Development, In Vitro, Drug Discovery, Drug Metabolism, In Vivo, Lc Ms.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial